HNN3.0
Register
Register
Register

Project cooperationUpdated on 17 December 2025

Partnership Oppportunities for 2026-01-DISEASE-03:

Founder, CEO at Galata Innovation

Istanbul, Türkiye

About

We are currently assembling a high-impact consortium for the HORIZON-HLTH-2026-01-DISEASE-03 call, focusing on the prevention, diagnosis, and management of post-infection long-term conditions. We are specifically seeking clinical partners interested in leading or contributing to multi-center clinical studies.

Similar opportunities

  • Project cooperation

    Effect of Long Term Exposure to toxins/environmental factors in Cell Models

    • Partner seeks Consortium/Coordinator
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions

    A ArunJunai

    Managing Director at EU-Support

    Roermond, Netherlands

  • Project cooperation

    Digital endpoint solution for motricity-affecting diseases seeks to join consortium for project call "DISEASE-03"

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions

    Charlotte Rasser

    Senior Strategy & Scientific Affairs Director at Sysnav

    Vernon, France

  • Project cooperation

    Monash University Health Research Capabilities

    Susan Feitoza

    Director Strategy and Engagement at Monash University

    Prato, Italy